← Leaderboards
Ravi S Kane
Rensselaer Polytechnic Institute
$6,866,225
Attributed
$12,051,049
Total exposure
10
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,051,049 · 10
By mechanism
R01$8,087,826 · 5
RF1$2,413,343 · 1
R21$1,400,530 · 3
R03$149,350 · 1
Top collaborators
- David V Schaffer10 shared
- Alberto Moreno3 shared
- Gabriele Neumann3 shared
- Randolph S Ashton2 shared
- Andrei G Fedorov2 shared
- Peter M Tessier2 shared
Most similar at Rensselaer Polytechnic Institute
Same institution · by research overlap
- Yunfeng Shi$2,100,738
- Pankaj S Karande$537,703
- Henrik Andersen$101,883
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignEngineeringIn VivoLigandsMediatingBaseCellsNanoscaleBiomimeticsBiologicalProteinsPublic HealthAntibodiesLifeSignal TransductionScaffoldStem Cell FateCell BehaviorNerve Stem CellComplexNeuronal DifferentiationSignal PathwayStem CellsViral
Grant awards (29)
Engineering Protein Antigens and their Presentation from Multivalent Scaffolds$812,281
R01 · FY2025 · AI · contact PI
Guided Intracellular Delivery using Precise Area Introduction and Transfection (PAINT)$471,484
R01 · FY2025 · GM
Engineering Protein Antigens and their Presentation from Multivalent Scaffolds$816,638
R01 · FY2024 · AI · contact PI
Guided Intracellular Delivery using Precise Area Introduction and Transfection (PAINT)$488,753
R01 · FY2024 · GM
Engineering Protein Antigens and their Presentation from Multivalent Scaffolds$851,964
R01 · FY2023 · AI · contact PI
Design and Evolution of Polyvalent Domain Antibodies Specific for Tau Aggregates$421,875
RF1 · FY2022 · AG
Design and evolution of polyvalent domain antibodies specific for tau aggregates$1,991,468
RF1 · FY2018 · AG
Optogenetic Characterization and Control of Stem Cell Signaling$339,841
R01 · FY2018 · NS
Multivalent Ligands to Control Stem Cell Fate$328,114
R01 · FY2018 · NS
Zika Virus Vaccines based on Nanoscale Constructs Presenting the Envelope Protein$197,684
R21 · FY2018 · AI · contact PI
Optogenetic Characterization and Control of Stem Cell Signaling$339,841
R01 · FY2017 · NS
Multivalent Ligands to Control Stem Cell Fate$328,114
R01 · FY2017 · NS
Zika Virus Vaccines based on Nanoscale Constructs Presenting the Envelope Protein$250,187
R21 · FY2017 · AI · contact PI
Optogenetic Characterization and Control of Stem Cell Signaling$339,841
R01 · FY2016 · NS
Multivalent Ligands to Control Stem Cell Fate$329,119
R01 · FY2016 · NS
Optogenetic Characterization and Control of Stem Cell Signaling$339,613
R01 · FY2015 · NS
Engineering Nanoscale Aptamer-based Biomaterials that Target Cellular Receptors$330,745
R01 · FY2015 · EB · contact PI
Multivalent Ligands to Control Stem Cell Fate$329,627
R01 · FY2015 · NS
Optogenetic Characterization and Control of Stem Cell Signaling$351,653
R01 · FY2014 · NS
Multivalent Ligands to Control Stem Cell Fate$342,382
R01 · FY2014 · NS
Engineering Nanoscale Aptamer-based Biomaterials that Target Cellular Receptors$311,102
R01 · FY2014 · EB · contact PI
Engineering Nanoscale Aptamer-based Biomaterials that Target Cellular Receptors$302,444
R01 · FY2013 · EB · contact PI
Engineering Nanoscale Aptamer-based Biomaterials that Target Cellular Receptors$334,270
R01 · FY2012 · EB · contact PI
Bioactive Materials for Stem Cell Control$195,625
R21 · FY2009 · EB · contact PI
Bioactive Materials for Stem Cell Control$250,000
R21 · FY2008 · EB · contact PI
The Design of Inhibitors of Anthrax Toxin$246,929
R21 · FY2004 · AI
The Design of Potent Divalent Inhibitors of HIV-1$72,100
R03 · FY2004 · AI
The Design of Inhibitors of Anthrax Toxin$260,105
R21 · FY2003 · AI
Design of Potent Divalent Inhibitors of HIV-1$77,250
R03 · FY2003 · AI